Geode Capital Management, LLC Talis Biomedical Corp Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.44 - $0.54 $1,709 - $2,098	-3,886 Reduced 2.69%	140,530 $67,000
Q4 2022 Feb 13, 2023	SELL	$0.45 - $11.67 $148 - $3,851	-330 Reduced 0.23%	144,416 $64,000
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.44 $97,327 - $173,027	-120,158 Reduced 45.36%	144,746 $117,000
Q1 2022 May 13, 2022	SELL	$1.3 - $4.19 $21,659 - $69,809	-16,661 Reduced 5.92%	264,904 $373,000
Q4 2021 Feb 11, 2022	SELL	$3.81 - $6.17 $81,545 - $132,056	-21,403 Reduced 7.06%	281,565 $1.13 Million
Q3 2021 Nov 12, 2021	BUY	$6.02 - $12.46 $270,448 - $559,765	44,925 Added 17.41%	302,968 $1.89 Million
Q2 2021 Aug 13, 2021	BUY	$9.62 - $14.56 $250,283 - $378,807	26,017 Added 11.21%	258,043 $2.85 Million
Q1 2021 May 12, 2021	BUY	$11.2 - $27.8 $2.6 Million - $6.45 Million	232,026 New	232,026 $2.98 Million

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.1M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.